Results

Total Results: 1,169 records

Showing results for "patient safety".

281. Web Interactive Presentation of EPC Reports: A Foray Into Interactive Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
     September 01, 2019 - Associate Chief Medical Officer for Patient Safety and Clinical Quality Assistant Professor of Medicine … with urinary incontinence, as well as health system decisions related to improving patient safety and … We engaged the Associate Chief Medical Officer (CMO) for Patient Safety and Clinical Quality and the … The Associate Chief CMO for Patient Safety and Clinical Quality is tasked with setting Duke’s quality … agenda and coordinating patient safety and clinical quality activities across the Duke Health System

282. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
     January 01, 2015 - We removed the word safety from the title for Table D. … We have discussed patient preference as well as cost briefly as potential drivers. … Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients … varies with patient characteristics. … 16 patients 0.2 in the placebo group P 0.42 definite acute pancreatitis in 17 patients 0.2 and 9 patients

283. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
     January 01, 2010 - of trauma experienced (including acute vs. chronic types of PTSD), timing of treatment initiation, patient … What patient characteristics (including those listed below) are associated with variations in treatment … Is there sufficient evidence to support treatment matching based on patient characteristics or resources … Indirect/media (location at time of exposure—degree of safety) 3. … Does this vary by age, sex, or other patient characteristics?

284. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, a potential increase in per-patient cost might serve as a barrier to acceptance by some patients … While preliminary results are promising, further studies evaluating efficacy and safety are needed, … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.

285. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - For this reason, it is also important to capture long-term safety to obtain a global aspect of how … these therapies impact patient care, both benefits and harms. … For KQ 1, what does this patient population look like? … Efficacy and safety of infliximab vs. … One patient was reported to have hypertension in patients who switched from methotrexate to infliximab

286. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
     August 23, 2010 - What are the potential safety issues and harms associated with the use of non-invasive diagnostic techniques … Guiding question 3: What published and unpublished studies have reported on the use and safety of these … Provide a synthesis of the following information: i Indication/patient inclusion criteria ii Type … of techniques/modalities iii Study design and size iv Role of the test in patient management v … Strategies for early melanoma detection: Approaches to the patient with nevi.

287. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with … Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic … Efficacy, tolerability and safety of cannabinoids for management of pain in adult patients with multiple … Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient. … Care of the Patient Using Cannabis.

288. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
     January 01, 2015 - 7% by week 39. 9 The safety and efficacy of the ITCA 650 pump system compared with twice-daily … Summary of safety and effectiveness data (SSED). MiniMed 530G system. P120010. … Important safety information: Animas Vibe insulin pump and CCGM system. [internet]. … Available: http://www.animas.com/safety. 27. … A study of the safety and efficacy of a new treatment for diabetic macular edema.

289. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm http://www.fda.gov/Safety/MedWatch/HowToReport … 9) How should input from technical and clinical experts and patients or patient advocacy groups be used … How should input from technical and clinical experts and patients or patient advocacy groups be used … Had to report data from groups of in which at least 85% of the patients were from one of the patient … What are the harms of therapeutic interventions for patients with ME/CFS and how do they vary by patient

290. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - Patients and their diabetes care team work to adjust patient insulin dosages using feedback from a … complications would lower long-term, per-patient costs for both patients and third- party payers. … Genentech has a patient-assistance program to help defray costs for qualified patients.175 Several … affecting patient acceptance. … Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus

291. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - But the experts called for longer safety and efficacy studies to determine whether this system would … Genentech has a patient assistance program to help defray costs for qualified patients.135 Several … Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to … Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used … Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus

292. Methods Report Appendix A: Foray Into Computable Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods-report-web-interactive-presentation-appendix-a.pdf
     May 29, 2025 - Bae, MD: Associate Chief Medical Officer for Patient Safety and Clinical Quality • G.

293. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
     September 29, 2011 - What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … volume, setting, guideline-based treatment protocols) Safety and adverse effects, including … The safety outcomes will be framed to help identify adverse events, including adverse drug reactions

294. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - On the other hand, some thought that knowing that a patient has AD could aid planning in terms of safety … and care of the patient … and care of the patient. … A diagnosis could, however, aid patients and families in planning for the patient’s care and safety. … AD patients.

295. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - data and postmarket safety evaluation, set forth by the U.S. … FDA expressed concerns about the long-term cardiovascular safety profile in the overweight and obese … Experts also opined that further studies evaluating efficacy and safety are needed. … quality of life, thus impacting patient health outcomes. … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.

296. psychiatric-readmissions-protocols-140904 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
     December 31, 2014 - demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … Search terms Search Query Items found #1 Search ("Patient Admission"[Mesh] OR "Patient Discharge" … "[All Fields] OR "Patient Readmission"[Mesh] OR "brief admission"[All Fields] OR "patient admission

297. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - The safety signal uncovered by the FDA was an excess of fetal death in patients exposed to 17P. … , of note each of these is mediated by the care provider as part of the process of care; none are patient … A it must work for patient B" clearly does not apply for 17OH. … Given that this document could be used to provide guidelines for patient care and change reimbursement … Physicians need to inform patients that there is a potential safety signal with the administration of

298. A Framework for Conceptualizing Evidence Needs of Health Systems (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
     December 01, 2017 - information, i.e., in the context of available resources and circumstances presented by individual patients … safety and quality of care. … 15 percent of the content of these protocols is routinely adapted to meet the needs of individual patients … outcome data) and external (published research) evidence for patients and clinicians.66 Our work … and value of patient care.

299. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … Many of the studies reported limited data on patient characteristics, and black patients appeared to

300. Osteoporosis-Vibration-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
     January 01, 2020 - When should patient outcomes be measured (length of followup)? … Questions for Clinicians, Patients, and Patient Advocates. a. … vibration (effectiveness, safety, FDA approval, doctor recommendation, other)? … Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials. … Population Country of residence of patients Inclusion criteria Exclusion criteria Number of patients